Clinical Trials Directory

Trials / Completed

CompletedNCT01085526

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Patients With Allergic Rhinitis Due to Grass Pollen Allergy - a Prospective Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The trial is randomized prospective study to examine the effects of subcutaneous immunotherapy on the adaptive immune system. The trial includes 30 participants randomized to treatment or control group. The effect measures are changes in the basophil activity and biology as well as changes in plasma cells during and after treatment. Clinical outcome is assessed by QoL questionnaires and clinical testing. Hypotheses: * changes in plasma cells correlate to changes in immunoglobulins and effector cell responses * the reduction of inflammation due to SCIT has influence on the effector cell responses * changes in paraclinical measurements can be related to clinical findings

Detailed description

The investigators are recruiting 30 participants, which are randomized to receive SCIT (24) or no treatment (6) The following will be measured * the development of immunoglobulin response * plasma cells under updosing phase * changes in basophil activity under updosing and maintenance treatment * subtyping of allergic sensitization * clinical outcome and quality of life * changes in mast cells in the nasal mucosa * changes in the cell biology of the basophils

Conditions

Interventions

TypeNameDescription
BIOLOGICALAlutard phleum pratense subcutaneous immunotherapystandard regimen of SCIT
DRUGAlutard phl prat

Timeline

Start date
2010-02-01
Primary completion
2014-07-01
Completion
2014-09-01
First posted
2010-03-12
Last updated
2015-02-18

Source: ClinicalTrials.gov record NCT01085526. Inclusion in this directory is not an endorsement.